224 related articles for article (PubMed ID: 4043827)
21. Novel oral anticoagulants and diet: the potential for interaction.
Kamali F
Am J Hematol; 2009 Apr; 84(4):260-1. PubMed ID: 19253346
[No Abstract] [Full Text] [Related]
22. Coagulation assays and anticoagulant monitoring.
Funk DM
Hematology Am Soc Hematol Educ Program; 2012; 2012():460-5. PubMed ID: 23233620
[TBL] [Abstract][Full Text] [Related]
23. Predictors of anticoagulation quality in 15 834 patients performing patient self-management of oral anticoagulation with vitamin K antagonists in real-life practice: a survey of the International Self-Monitoring Association of Orally Anticoagulated Patients.
Schaefer C; Wuillemin WA; Kessels A; Jacobson A; Nagler M
Br J Haematol; 2016 Nov; 175(4):677-685. PubMed ID: 27468696
[TBL] [Abstract][Full Text] [Related]
24. Vitamin K and thrombosis.
Merli GJ; Fink J
Vitam Horm; 2008; 78():265-79. PubMed ID: 18374199
[TBL] [Abstract][Full Text] [Related]
25. [Mechanisms of action of oral anticoagulants].
Uszyński L
Acta Haematol Pol; 1972; 3(2):133-9. PubMed ID: 4655612
[No Abstract] [Full Text] [Related]
26. Measurement of Non-Vitamin K Antagonist Oral Anticoagulants in Patient Plasma Using Heptest-STAT Coagulation Method.
Du S; Harenberg J; Krämer S; Krämer R; Wehling M; Weiss C
Ther Drug Monit; 2015 Jun; 37(3):375-80. PubMed ID: 25525760
[TBL] [Abstract][Full Text] [Related]
27. Plasma disposition of vitamin K1 in relation to anticoagulant poisoning.
Park BK; Scott AK; Wilson AC; Haynes BP; Breckenridge AM
Br J Clin Pharmacol; 1984 Nov; 18(5):655-62. PubMed ID: 6508974
[TBL] [Abstract][Full Text] [Related]
28. New oral anticoagulants in development.
Weitz JI
Thromb Haemost; 2010 Jan; 103(1):62-70. PubMed ID: 20062934
[TBL] [Abstract][Full Text] [Related]
29. High usual dietary vitamin K intake is associated with low relative variability in vitamin K intake: implications for anticoagulant therapy.
Presse N; Kergoat MJ; Ferland G
Br J Haematol; 2011 Apr; 153(1):129-30. PubMed ID: 21275964
[No Abstract] [Full Text] [Related]
30. Dietary implications for patients receiving long-term oral anticoagulation therapy for treatment and prevention of thromboembolic disease.
Kampouraki E; Kamali F
Expert Rev Clin Pharmacol; 2017 Aug; 10(8):789-797. PubMed ID: 28635328
[TBL] [Abstract][Full Text] [Related]
31. VKORC1: a warfarin-sensitive enzyme in vitamin K metabolism and biosynthesis of vitamin K-dependent blood coagulation factors.
Wallin R; Wajih N; Hutson SM
Vitam Horm; 2008; 78():227-46. PubMed ID: 18374197
[TBL] [Abstract][Full Text] [Related]
32. Recent findings in understanding the biological function of vitamin K.
Uotila L; Suttie JW
Med Biol; 1982 Feb; 60(1):16-24. PubMed ID: 6803084
[TBL] [Abstract][Full Text] [Related]
33. [Influence of SKF 525A on the kinetics and action of an antivitamin K in the rat].
Thonnart N; Letist D; Reuse J
Arch Int Pharmacodyn Ther; 1974 Apr; 208(2):369-72. PubMed ID: 4848952
[No Abstract] [Full Text] [Related]
34. Considerations for long-term anticoagulant therapy in patients with venous thromboembolism in the novel oral anticoagulant era.
Toth PP
Vasc Health Risk Manag; 2016; 12():23-34. PubMed ID: 26929637
[TBL] [Abstract][Full Text] [Related]
35. Orally active direct thrombin inhibitors.
Weitz J
Semin Vasc Med; 2003 May; 3(2):131-8. PubMed ID: 15199476
[TBL] [Abstract][Full Text] [Related]
36. Membrane-dependent reactions in blood coagulation: role of the vitamin K-dependent enzyme complexes.
Kalafatis M; Swords NA; Rand MD; Mann KG
Biochim Biophys Acta; 1994 Nov; 1227(3):113-29. PubMed ID: 7986819
[No Abstract] [Full Text] [Related]
37. [Vitamin K epoxide reductase: Fresh blood for oral anticoagulant therapies].
Loriot MA; Beaune P
Rev Med Interne; 2006 Dec; 27(12):979-82. PubMed ID: 17070618
[TBL] [Abstract][Full Text] [Related]
38. Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: proposals of the working group on perioperative haemostasis (GIHP) - March 2013.
Pernod G; Albaladejo P; Godier A; Samama CM; Susen S; Gruel Y; Blais N; Fontana P; Cohen A; Llau JV; Rosencher N; Schved JF; de Maistre E; Samama MM; Mismetti P; Sié P;
Arch Cardiovasc Dis; 2013; 106(6-7):382-93. PubMed ID: 23810130
[TBL] [Abstract][Full Text] [Related]
39. [Mechanism of action of vitamin K and how it is affected by anticoagulants].
Schade R; Janowski K
Pharmazie; 1976; 31(9):585-9. PubMed ID: 798207
[No Abstract] [Full Text] [Related]
40. PPSB as first choice treatment in the reversal of oral anticoagulant therapy.
Strengers PF; Drenth JC
Acta Anaesthesiol Belg; 2002; 53(3):183-6. PubMed ID: 12461827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
